ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 182986 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 182986; 2) Community: the network communities that were significantly associated with the response to NSC 182986; 3) Molecule: the relationships between components within communities and NSC 182986; 4) MDR: the compounds that were significantly associated with the NSC 182986.

NSC Compound Enrichment Correlation
NSC 697747 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-methoxyphenyl)- 0.0241085022307781 0.19365512
NSC 742417 C8, carbonyl prodigiosine 0.0241085022307781 0.38624203
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0244632509325736 0.090393171
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0244632509325736 0.17178629
NSC 363812 Tetraplatin 0.0244632509325736 0.3837176
NSC 376248 Nordracorubin 0.0244632509325736 0.27227463
NSC 46213 Null 0.0244632509325736 -0.11602995
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.0244632509325736 0.36279418
NSC 656203 Discorhabdin B 0.0244632509325736 -0.019602279
NSC 667269 Null 0.0244632509325736 0.10479321
Total:71  Current:41    [First] [Prev] [Next] [Last]